TMA7 (translation machinery associated 7 homolog) is a translation-associated protein with emerging roles in cellular regulation and disease pathogenesis. Functionally, TMA7 is involved in translation machinery processes, as demonstrated by yeast studies showing that TMA7 deletion causes alterations in protein synthesis rates, increased susceptibility to translation-inhibiting drugs, and disrupted polyribosome profiles 1. In laryngeal squamous cell carcinoma (LSCC), TMA7 is upregulated and promotes disease progression through suppression of autophagy via the IGF2BP3-TMA7-UBA2-PI3K pathway, with high TMA7 expression associated with poor prognosis and cisplatin resistance 2. TMA7 expression is also regulated by DNA methylation in response to nutritional stress, with differential methylation patterns identified in individuals exposed to famine 3. Clinically, TMA7 has been identified as a putative biomarker for primary induction failure in pediatric acute myeloid leukemia, showing overexpression in chemotherapy-resistant patients 4. Additionally, TMA7 emerged as an immune cell-specific genetic contributor to migraine susceptibility with minimal adverse associations, suggesting potential as a therapeutic target in precision migraine medicine 5. These findings position TMA7 as a multifunctional protein linking translation machinery to autophagy regulation and disease progression across multiple pathological contexts.